Navigation Links
Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress

Patients treated with Satraplatin Demonstrated Statistically Significant Improvement in Pain Response and PSA Response Rates

BERLIN, March 22, 2007 /PRNewswire-FirstCall/ -- Pharmion Corporation and GPC Biotech AG today announced additional data from the double-blind, randomized satraplatin Phase 3 registrational trial, the SPARC trial (Satraplatin and Prednisone Against Refractory Cancer) which were presented today at the 22nd Annual European Association of Urology Congress in Berlin, Germany. The trial is evaluating satraplatin plus prednisone versus placebo plus prednisone in 950 patients with hormone-refractory prostate cancer (HRPC) who have failed prior chemotherapy.

"Second-line chemotherapy for patients with hormone-refractory prostate cancer represents a true unmet medical need and the encouraging satraplatin data suggest that for the first time, we may have a treatment option for these patients with advanced disease," said Professor Fred Witjes, Professor of Urology, Academisch Ziekenhuis, Nijmegen, The Netherlands. "In particular, the very impressive pain and PSA response rates seen in the SPARC study, especially considering the fact that all these patients were progressive after hormones and chemotherapy, further suggest satraplatin's active anti-tumor effect in this patient population."

Data presented today from the SPARC study showed that pain response rates for patients treated with satraplatin were statistically significantly superior compared to the pain response rates for those patients in the comparator arm. Pain response rates were 24.2 percent for the satraplatin plus prednisone arm compared with 13.8 percent for the placebo arm (p=0.005).

Pain response was assessed by patients using a weekly present pain intensity (PPI) and analgesic score. The PPI score was defined according to the McGill-Melzack questionnaire with 0 = no pain, 1 = mild pain, 2 = discomforting pain, 3
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
Post Your Comments:
(Date:9/17/2014)... NEW YORK and SAN JOSE, Calif. ... Systems has been named as a laureate of The ... recognized for applying technology to benefit humanity and spark global ... Museum of Innovation, and presented by Applied Materials, Inc., selected ... Award category. Photo - http://photos.prnewswire.com/prnh/20140917/146680 ...
(Date:9/17/2014)... 17, 2014  Lightbeam Health Solutions announced today ... (Physician Direct ACO) to deploy the Lightbeam population ... better care while reducing costs. Photo ... Direct Accountable Care Organization is the ACO operating ... OPNS mission is to be the premier integrated ...
(Date:9/17/2014)... , Sept. 17, 2014 An analysis ... regarding patients taking Sovaldi® (sofosbuvir), a new and expensive ... shows that over the last several months (May through ... downward trend in Sovaldi utilization. This suggests another surge ... new therapeutic regimens of similar efficacy and shorter duration ...
Breaking Medicine Technology:Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 2CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 4
(Date:9/17/2014)... Smart Flour Foods™ has been chosen as one ... trade magazine targeted toward food retailers. The delicious Uncured ... other attributes. Smart Flour Foods’ Uncured Pepperoni Pizza will ... print issue of Progressive Grocer as well as on ... on its superior performance in the following criteria: innovation ...
(Date:9/17/2014)... 2014 Cadiz Laser Spa offers ... procedures to clients throughout Central Texas. The newest ... Collagen Induction Therapy. Using the revolutionary Rejuvapen micro-needling ... help clients correct a wide variety of skin ... and Cadiz Laser Spa is currently offering a ...
(Date:9/17/2014)... News) -- Managing diabetes, quitting smoking, controlling high blood ... the risk for dementia -- even late in life, ... Report 2014, commissioned by Alzheimer,s Disease International, revealed that ... percent. The study noted that obesity and an inactive ... as high blood pressure. The researchers suggested ...
(Date:9/17/2014)... an analysis of genetic information among more than 87,000 ... found 23 new genetic variants common differences in ... for prostate cancer. The so-called "meta-analysis," believed to be ... mutations among men in a broad array of ethnic ... ancestry. , The meta-analysis combined information from smaller studies, ...
(Date:9/17/2014)... In a country where 77% of inhabitants ... basis, how can Americans find healthy and fulfilling ways ... Challenge , a 5-day interactive journey to putting stress ... From September 29th – October 3rd, the Hyland’s Stress ... specific topics that promote natural solutions for managing stress. ...
Breaking Medicine News(10 mins):Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2Health News:Revolutionary Collagen Induction Therapy is Now Available at Cadiz Laser Spa 2Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 2Health News:Healthy Lifestyle Changes Linked to Reduced Risk for Dementia 3Health News:Large study reveals new genetic variants that raise risk for prostate cancer 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2
... ... ,and Create New Categories that Advance Consumer Wellness,XanGo continues to expand mangosteen category it ... Conlee, President and CEO of XanGo, LLC, , ... Lehi, UT (PRWEB) March 13, 2010 -- Global wellness ...
... knee (anterior cruciate ligament) reconstruction with a patellar tendon ... of the tibia or shin bone) graft continue at ... to a study presented today at the American Orthopaedic ... Louisiana (March 13). Additionally, these patients have not developed ...
... by Indiana University Bloomington and Arizona State University geographers could ... reforming sex offender laws. The researchers describe the model and ... Papers in Regional Science. By forcing ... model can help the policymakers of concerned communities to focus ...
... LOS ANGELES , March 12 Persistent back ... as well as with a person,s enjoyment of life; from sports ... a critical key to remaining mobile. For people who have tried ... Orthopedic Spine Surgery is an inevitable course of treatment. ...
... , FRANKLIN, Tenn. , March 12 ... chairman, president and chief executive officer, Wayne T. Smith , ... , have been recognized by Institutional Investor magazine as ... the healthcare and managed care sectors. This is the fourth consecutive ...
... U.S. Army Accessions Command (USAAC) and Health Occupations Students of America, Inc. (HOSA) today signed a Memorandum of ... leadership qualities necessary for success in health care-focused careers and beyond. , ... ... , ...
Cached Medicine News:Health News:State of the Health & Wellness Category: 2010 2Health News:State of the Health & Wellness Category: 2010 3Health News:State of the Health & Wellness Category: 2010 4Health News:State of the Health & Wellness Category: 2010 5Health News:15 years after ACL knee reconstruction, 84 percent of male patients still highly active, study says 2Health News:Mathematical model can help communities better evaluate sex offender policies 2Health News:Mathematical model can help communities better evaluate sex offender policies 3Health News:World Renowned Los Angeles Surgeon Pioneers Alternative Orthopedic Spine Surgery 2Health News:Community Health Systems, Inc.'s Wayne T. Smith and Larry Cash Named America's Top Healthcare CEO and CFO 2Health News:Health Occupations Students of America, Inc. and the U.S. Army Sign Memorandum of Understanding in Support of Improving Career Options for Nation's Students 2Health News:Health Occupations Students of America, Inc. and the U.S. Army Sign Memorandum of Understanding in Support of Improving Career Options for Nation's Students 3
... This direct-acting inserter grasps the thinnest portion ... resulting in a minimum incision requirement. The ... the thicker center of the optic and ... resulting in delivery of an implant through ...
... inserter allows insertion of AMO SI-30 and SI-40 ... millimeters, and is perfect for clear corneal and ... has highly polished 6.5 millimeter rounded blades for ... tips of the blades have a .15 millimeter ...
... KR-8000PA Supra Auto-Kerato Refractometer combines an auto-refractor, ... mapping system all in a single, compact ... three times the diagnostic capabilities in one-third ... cost of the individual instruments. By implementing ...
Neomycin and Polymyxin B Sulfates and Hydrocortisone ophthalmic suspension is a sterile antimicrobial and anti-inflammatory suspension for ophthalmic use....
Medicine Products: